Life Science – Gene Therapies Provide New Hope for Families
I wanted to follow up my last post about breakthrough therapies with something a little less clinical and a little more personal. Last month I had the honor of attending a luncheon hosted by the Calli...
Great piece from @samirkaji on why emerging mgrs are critical to a well-rounded #VC portfolio:
-Clear focus on core ... competency & maximizing rtrns
-Alignment w investors (motivated to “emerge”)
-Opportunity to gen outsized outcomes from a single position
Q2 2022 US Valuations Report x @PitchBook:
Only 10 public listings for companies valued $1B+ were recorded through June... 30, compared with 100+ in 2021. Early-stage median pre-💰 valuations fell 16% in Q2 to $52M.
Full Report 📖👇 https://bit.ly/3QkszpM
TY @shomikghosh21 for allowing @Beezer232 to share the #LP perspective in Software Snack Bites🥨!
Take a read through... for an overview of the current state of the LP market: What GPs should know, portfolio allocation, investment strategy & tips for managing the GP/LP relationship
🚀@ttunguz shares interesting data to show the value generated by a successful software startup per every #VC dollar ... raised. For the last 30 years, this has been 10x, though it's volatile. Tomasz breaks it down here: http://bit.ly/3AedEIo